Year archive

XTL Biopharmaceuticals Ltd. — 2025 filings

All 37 regulatory filings released by XTL Biopharmaceuticals Ltd. (XTLB) in 2025, sourced directly from the official regulator.

37 Filings

2025 Period

2025 filings (37)

Filing	Released	Lang
Immediate Report Interim / Quarterly Report H1 2025	2025-12-30	English
Immediate Report Report Publication Announcement	2025-12-30	English
6-K Filing Foreign Filer Report	2025-12-30	English
Immediate Report Regulatory Filings	2025-12-30	English
Immediate Report Regulatory Filings FY 2025	2025-12-30	English
Immediate Report Board/Management Information	2025-12-14	English
Immediate Report Report Publication Announcement	2025-12-14	English
resignation of officers in a subsidiary Board/Management Information	2025-12-14	English
resignation of officers in a subsidiary Report Publication Announcement FY 2025	2025-12-14	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-12-12	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-12-05	English
Immediate Report Board/Management Information	2025-10-24	English
Immediate Report Board/Management Information FY 2025	2025-10-24	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-10-23	English
Immediate Report Declaration of Voting Results & Voting Rights Announcements	2025-07-29	English
Immediate Report Report Publication Announcement	2025-07-29	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-07-28	English
Immediate Report AGM Information	2025-07-23	English
Immediate Report Report Publication Announcement	2025-07-23	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-07-21	English
AMENDMENT NO. 1 TO FORM 6-K Foreign Filer Report	2025-06-18	English
Immediate Report of Meeting to be held on July 21, 2025 Director's Dealing	2025-06-15	English
Immediate Report of Meeting to be held on July 21, 2025 Proxy Solicitation & Information Statement	2025-06-15	English
Immediate Report of Meeting to be held on July 21, 2025 AGM Information	2025-06-15	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-06-13	English
FORM 20-F For the fiscal year ended December 31, 2024 Annual Report FY 2024	2025-04-30	English
FORM 20-F For the fiscal year ended December 31, 2024 Report Publication Announcement	2025-04-30	English
ANNUAL REPORT Annual Report FY 2024	2025-04-30	English
Noam Band was appointed the Chief Executive Officer, Mr. Band replaces Shlomo Shalev who will continue to serve as the Chairman of the Company’s Board of Directors Board/Management Information	2025-04-07	English
Noam Band was appointed the Chief Executive Officer, Mr. Band replaces Shlomo Shalev who will continue to serve as the Chairman of the Company’s Board of Directors Report Publication Announcement	2025-04-07	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-04-07	English
Definitive Exclusive Sublicense Agreement with Biossil, a company incorporated under the laws of Canada Regulatory Filings	2025-03-04	English
Definitive Exclusive Sublicense Agreement with Biossil, a company incorporated under the laws of Canada Regulatory Filings	2025-03-04	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-03-04	English
. Tal Klinger’s and Yair Redl’s decisions to resign from the Board were not due to any disagreement with the Company or its management Board/Management Information	2025-02-03	English
. Tal Klinger’s and Yair Redl’s decisions to resign from the Board were not due to any disagreement with the Company or its management Report Publication Announcement	2025-02-03	English
REPORT OF FOREIGN PRIVATE ISSUER Foreign Filer Report	2025-02-03	English

Filings by year

2026 47 filings
2025 37 filings
2024 48 filings
2023 33 filings
2022 19 filings
2021 42 filings
2020 36 filings
2019 19 filings
2018 45 filings
2017 80 filings
2016 76 filings
2015 56 filings
2014 97 filings
2013 74 filings
2012 32 filings
2011 19 filings
2010 15 filings
2009 51 filings
2008 157 filings
2007 124 filings
2006 61 filings
2005 52 filings
2004 1 filing